Qol Co Ltd (3034)

Currency in JPY
2,419.0
+325.0(+15.52%)
Closed·
Advertisement
Unusual trading volume
Trading near 52-week High
3034 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,300.02,563.0
52 wk Range
1,681.02,563.0
Key Statistics
Bid/Ask
2,418.00 / 2,430.00
Prev. Close
2,094
Open
2,316
Day's Range
2,300-2,563
52 wk Range
1,681-2,563
Volume
726.3K
Average Volume (3m)
164.89K
1-Year Change
12.8265%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3034 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1,900.0
Downside
-21.46%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 1,900.0
(-21.46% Downside)

Earnings

Latest Release
07/08/2026
EPS / Forecast
79.90 / --
Revenue / Forecast
73.91B / 65.3B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 227.83%
Dividend Yield
2.58%
Industry Median 1.93%
Annualised payout
54.00
Paid unevenly
5-Years Growth
+12.30%
Growth Streak

Compare 3034 to Peers and Sector

Metrics to compare
3034
Peers
Sector
Relationship
P/E Ratio
10.6x12.7x11.7x
PEG Ratio
0.29−0.210.03
Price/Book
1.4x1.1x1.5x
Price / LTM Sales
0.3x0.2x0.9x
Upside (Analyst Target)
−21.5%12.3%22.9%
Fair Value Upside
Unlock25.0%13.4%Unlock

Qol Holdings Co., Ltd., together with its subsidiaries, engages in the pharmacy, BPO, and pharmaceutical businesses in Japan. The company operates dispensing pharmacies through one-on-one store opening based on one-on-one trust relationships with medical institutions. It also provides contract MR staffing; clinical research and development support services in the areas of food and pharmaceuticals; education and training services; and dispatch clinical research associates to support clinical trials. In addition, the company produce sales promotion materials for pharmaceuticals, as well as pamphlets and websites for medical institutions. Further, it engages in pharmaceutical manufacturing business; medical professional referral and dispatch business for the business areas, including pharmacist, medical clerical work, dispensing work, occupational physician, health nurse, nurse, and registered sales clerk; and business succession, health, and productivity management consulting business. The company was formerly known as Qol Co., Ltd. and changed its name to Qol Holdings Co., Ltd. in October 2018. The company was founded in 1992 and is headquartered in Tokyo, Japan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.61M12.26%9.65B
Other Institutional Investors
26.08M69.41%54.62B
Public Companies & Retail Investors
6.89M18.33%14.42B
Total
37.58M100.00%78.69B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
MediPal Holdings Corporation20.18%7,582,80015,878,383
Will Field Capital Pte. Ltd.18.35%6,896,90014,442,109

FAQ

What Is the Qol Co Ltd (Tokyo: 3034) Share Price Today?

The Qol Co Ltd stock price today is 2,419.0 JPY.

What Stock Exchange Does Qol Co Ltd (3034) Trade On?

Qol Co Ltd is listed and trades on the Tokyo Stock Exchange.

What Is the Ticker (Stock Symbol) for Qol Co Ltd?

The stock symbol (also called a 'ticker') for Qol Co Ltd is "3034."

Does Qol Co Ltd Pay Dividends? What’s The Current 3034 Dividend Yield?

Yes, 3034 Pays Dividends to its Shareholders. The current Qol Co Ltd dividend yield is 2.23%.

What Is the Current Qol Co Ltd Market Capitalisation?

As of today, Qol Co Ltd (Tokyo: 3034) market cap is 90.9B JPY.

What Is Qol Co Ltd's (3034) Earnings Per Share (TTM)?

The Qol Co Ltd EPS is currently 227.8 (Trailing Twelve Months).

When Is the Next Qol Co Ltd Earnings Date?

Qol Co Ltd's next earnings report will be released on 30/10/2026.

Is 3034 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Qol Co Ltd moving averages and other technical indicators, the daily buy/sell signal for 3034 stock is Strong Buy.

How Many Times Has Qol Co Ltd Stock Split?

Qol Co Ltd has split 4 times. (See the 3034 stock split history page for full effective split date and price information.)

What is the current trading status of Qol Co Ltd (Tokyo: 3034)?

As of 11/08/2026, Qol Co Ltd (3034) is trading at a share price of 2,419.0 JPY, with a previous close of 2,094.0 JPY. The stock has fluctuated within a day range of 2,300.0 JPY to 2,563.0 JPY, while its 52-week range spans from 1,681.0 JPY to 2,563.0 JPY.

What Is Qol Co Ltd (3034) Price Target According to Analysts?

The average 12-month price target for Qol Co Ltd is 1,900.0 JPY, with a high estimate of 1900 JPY and a low estimate of 1900 JPY. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -21.46% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.